Erste Group upgraded AstraZeneca to Buy from Hold.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca downgraded to Sell from Hold at Nordea
- AstraZeneca Shares Fall on Lung Cancer Drug Trial’s Outcome
- Sophia Genetics announces collaboration agreement with AstraZeneca
- J&J Rybrevant/Lazcluze study shows superiority over lazertinib for NSCLC
- AstraZeneca says Dato-DXd showed clinically meaningful trend toward improving OS
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue